The Weblog for News and Views on the Clinical Trials IndustryClinical Trials Today, Part of the Centerwatch Network
CenterWatch
Clinical Trials Today: The weblog for opinions, news, and views on the Clinical Trials Industry

« Magic Johnson—Celebrity Spokesperson for Minority Patient Recruitment? | Main | Bio's National Investor Conference Plays Matchmaker »

CWWeekly April 14th 2008 Issue

Cwweekly_april_14th_2008_issue

Top News
      
Coast IRB Receives FDA Warning Letter

Coast IRB, an independent institutional review board (IRB) based in Colorado Springs, Colo., received a Warning Letter from the U.S. Food and Drug Administra-tion (FDA) concerning the company’s improper expedited review of a phase I study being conducted in northern California. In an unusual move, the agency has temporarily suspended the IRB’s ability to do expedited reviews.

LabConnect Gains Centralized Pathology Testing with Bostwick Scientific Deal

LabConnect, a clinical trial–focused central laboratory provider based in Seattle, Wash., has inked an agreement with Bostwick Laboratories, adding one of the top anatomic pathology testing companies to its international list of networked labs.
      
Other breaking news...      

Company Profile: An interview with Paul Bishop, managing partner, and Lyle Camblos, managing partner, Atlantic Research Group

To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information. Past weekly article summaries for the year can be found in the CW Weekly Issue archives.


 

Comments

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/t/trackback/697361/28253082

Listed below are links to weblogs that reference CWWeekly April 14th 2008 Issue:

Site Identification Services Product and Service Providers Clinical Trial Results Drugs in Clinical Trials Professional Bookstore Advertising Opportunities